Showing results (101-110 of 235) with videos related to
Sort By:
Pageof 24
AIDS Research and Human Retroviruses|June 22, 2010
Age-related changes in plasma concentrations of the HIV protease inhibitor lopinavirKeith W Crawford, John Spritzler, Robert C Kalayjian, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 19, 2012
Safety, tolerability, and pharmacokinetics of the HIV integrase inhibitor dolutegravir given twice daily with rifampin or once daily with rifabutin: results of a phase 1 study among healthy subjectsKelly E Dooley, Patrick Sayre, Julie Borland, et al.AIDS (London, England)|December 1, 2021
Impact of long-acting therapies on the global HIV epidemicNomathemba C Chandiwana, Celicia M Serenata, Andrew Owen, et al.ACS Omega|July 21, 2025
Structure-Activity Relationship Studies of Emtricitabine Prodrugs toward Long-Acting Antiretroviral FormulationsAmer Al-Khouja, Stephanie Henriquez, James J Hobson, et al.Antimicrobial Agents and Chemotherapy|July 13, 2011
Pharmacokinetic modeling of plasma and intracellular concentrations of raltegravir in healthy volunteersLingzhi Wang, Gaik Hong Soon, Kok-Yong Seng, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 29, 2012
Biphasic elimination of tenofovir diphosphate and nonlinear pharmacokinetics of zidovudine triphosphate in a microdosing studyJianmeng Chen, Charles Flexner, Rosa G Liberman, et al.The Journal of Antimicrobial Chemotherapy|March 1, 2019
Rifampicin effect on intracellular and plasma pharmacokinetics of tenofovir alafenamideMaddalena Cerrone, Omamah Alfarisi, Megan Neary, et al.Nature Communications|March 31, 2019
Semi-solid prodrug nanoparticles for long-acting delivery of water-soluble antiretroviral drugs within combination HIV therapiesJames J Hobson, Amer Al-Khouja, Paul Curley, et al.Evolution; International Journal of Organic Evolution|April 22, 2003
Breakdown in correlations during laboratory evolution. II. Selection on stress resistance in Drosophila populationsMargaret A Archer, John P Phelan, Kelly A Beckman, et al.Disability and Rehabilitation|October 4, 2021
The validity of the International Physical Activity Questionnaire (IPAQ) for adults with progressive muscle diseasesSarah F Roberts-Lewis, Claire M White, Mark Ashworth, et al.Pageof 24